Reaction Details Report a problem with these data
Target
Dual specificity protein kinase CLK2
Ligand
BDBM50590216
Substrate
n/a
Meas. Tech.
ChEMBL_2195621 (CHEMBL5108137)
IC50
67±n/a nM
Citation
Gulati, A; Yeung, CS; Lapointe, B; Kattar, SD; Gunaydin, H; Scott, JD; Childers, KK; Methot, JL; Simov, V; Kurukulasuriya, R; Pio, B; Morriello, GJ; Liu, P; Tang, H; Neelamkavil, S; Wood, HB; Rada, VL; Ardolino, MJ; Yan, XC; Palte, R; Otte, K; Faltus, R; Woodhouse, J; Hegde, LG; Ciaccio, P; Minnihan, EC; DiMauro, EF; Fell, MJ; Fuller, PH; Ellis, JM Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors. RSC Med Chem 12:1164-1173 (2021) [PubMed]
More Info.:
Target
Name:
Dual specificity protein kinase CLK2
Synonyms:
2.7.12.1 | CDC-like kinase 2 | CDC-like kinase 2 (CLK2) | CDC2-like kinase 2 (CLK2) | CLK2 | CLK2_HUMAN
Type:
n/a
Mol. Mass.:
60128.79
Organism:
Homo sapiens (Human)
Description:
P49760
Residue:
499
Sequence:
MPHPRRYHSSERGSRGSYREHYRSRKHKRRRSRSWSSSSDRTRRRRREDSYHVRSRSSYDDRSSDRRVYDRRYCGSYRRNDYSRDRGDAYYDTDYRHSYEYQRENSSYRSQRSSRRKHRRRRRRSRTFSRSSSQHSSRRAKSVEDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSRDISR